Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Olive Leaf Extract Health-Promoting and Anti-Tumor Properties: An Adjunct Therapy in Pediatric Oncology?

Nutrients·2026
Same author

B7-H3 CAR T cells eradicate intrahepatic cholangiocarcinoma and induce durable response.

Journal of experimental & clinical cancer research : CR·2026
Same author

A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation.

Cell transplantation·2026
Same author

Antimetastatic activity of B7-H3-targeted CAR T-cell therapy in triple-negative breast cancer.

Cancer letters·2026
Same author

The immunosuppressive role of HLA-G<sup>+</sup> extracellular vesicles in bone marrow of infiltrating tumors: the lesson learned from neuroblastoma and multiple myeloma.

Human immunology·2026
Same author

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jul 11, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Soluble HLA-G: Are they clinically relevant?

Vito Pistoia1, Fabio Morandi, Xinhui Wang

  • 1Laboratory of Oncology, G.Gaslini Children's Hospital, Genoa, Italy. vitopistoia@ospedale-gaslini.ge.it

Seminars in Cancer Biology
|September 11, 2007
PubMed
Summary

Soluble human leukocyte antigen-G (sHLA-G) plays a key role in immune tolerance. This review examines sHLA-G serum levels in various diseases, focusing on neuroblastoma and its immune evasion strategies.

More Related Videos

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Experiment Videos

Last Updated: Jul 11, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Human Leukocyte Antigen-G (HLA-G) is a non-classical HLA class Ib molecule.
  • HLA-G possesses significant immunoregulatory functions, crucial for maternal-foetal tolerance.
  • HLA-G exists in both membrane-bound and soluble forms (sHLA-G) in bodily fluids.

Purpose of the Study:

  • To review sHLA-G serum levels across diverse pathological conditions.
  • To investigate sHLA-G expression and function in pediatric neuroblastoma (NB).
  • To explore novel immune escape mechanisms in NB involving sHLA-G.

Main Methods:

  • Literature review of studies on sHLA-G serum levels.
  • Analysis of sHLA-G expression and function in neuroblastoma.
  • Examination of monocyte-mediated sHLA-G production in NB.

Main Results:

  • sHLA-G levels are altered in immune-mediated disorders, transplantation, and malignancies.
  • Neuroblastoma utilizes sHLA-G for immune evasion by instructing monocytes.
  • Soluble HLA-G1 and HLA-G5 are the predominant serum isoforms.

Conclusions:

  • sHLA-G is a relevant biomarker in various pathologies.
  • Neuroblastoma employs a unique mechanism involving monocytes to release sHLA-G, facilitating immune escape.
  • The clinical utility of monitoring sHLA-G serum levels warrants further investigation.